Wortmannin inhibits the growth of mammary tumors despite the existence of a novel wortmannin-insensitive phosphatidylinositol-3-kinase

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue 6, 1999, Pages 491-497

  Lemke, Leslie E ^a,b   Paine Murrieta, Gillian D ^a   Taylor, Charles W ^a   Powis, Garth ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cancer; Phosphatidylinositol 3 kinase; Wortmannin

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; WORTMANNIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST TUMOR; CANCER CONTROL; CANCER GROWTH; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; ANIMALS; BREAST NEOPLASMS; CELL DIVISION; ENZYME INHIBITORS; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C3H; MICE, SCID; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032735708     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051123     Document Type: Article

References (23)

1. 1. Abraham RT (1996) Phosphatidylinositol 3-kinase related kinases. Curr Opin Immunol 8: 412
2. 2. Boulton S, Kyle S, Yalcintepe L, Durkacz BW (1996) Wortmannin is a potent inhibitor of DNA double strand break but not single strand break repair in Chinese hamster ovary cells. Carcinogenesis 17: 2285
3. 3. Brunn GJ, Williams J, Sabers C, Wiederrecht G, Lawrence JC Jr., Abraham RT (1996) Direct inhibition of the signaling functions of the mammalian target of rapamycin by the phosphoinositide 3-kinase inhibitors, wortmannin and LY294002. EMBO J 15: 5256
4. 4. Carpenter CL, Cantley LC (1990) Phosphoinositide kinases. Biochemistry 29: 11147
5. 5. Domin J, Pages F, Volinia S, Rittenhouse SE, Zvelebil MJ, Stein RC (1997) Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J 326: 139
6. 6. Frew T, Powis G, Berggren M, Abraham RT, Ashendel CL, Zalkow LH, Hudson C, Qazia S, Gruszecka-Kowalik E, Merriman R, Bonjouklian R (1994) A multiwell assay for inhibitors of phosphatidylinositol-3-kinase and the identification of natural product inhibitors. Anticancer Res 14: 2425
7. 7. Frew T, Powis G, Berggren M, Gellegos A, Abraham RT, Ashendel CL, Zalkow LH, Hudson C, Gruszecka-Kowalik E, Burgess EM, Benedetti-Doctorovich V, Kerrigan JE, Lambropoulos J, Merriman R, Bonjouklian R (1995) Novel quinone antiproliferative inhibitors of phosphatidylinositol-3-kinase. Anticancer Drug Design 10: 347
8. 8. Hazeki O, Hazeki K, Katada T, Ui M (1996) Inhibitory effect of wortmannin on phosphatidylinositol 3-kinase-mediated cellular events. J Lipid Mediat Cell Signal 14: 259
9. 9. Hunter T (1995) When is a lipid kinase not a lipid kinase? When it is a protein kinase. Cell 83: 1
10. 10. Kaplan DR, Whitman M, Schaffhausen B, Pallas DC, White M, Cantley L, Roberts TM (1987) Common elements in growth factor stimulation and oncogenic transformation: 85 kd phosphoprotein and phosphatidylinositol kinase activity. Cell 50: 1021
11. 11. Keith CT, Schreiber SL (1995) PIK-related kinases: DNA repair, recombination, and cell cycle checkpoints. Science 270: 50
12. 12. Kozikowski AP, Kiddle JJ, Frew T, Berggren M, Powis G (1995) Synthesis and biology of 1D-3-deoxyphosphatidylinositol: a putative antimetabolite of phosphatidylinositol-3-phosphate and an inhibitor of cancer cell colony formation. J Med Chem 38: 1053
13. 13. Powis G, Kozikowski A (1994) Inhibitors of myo-inositol signalling. In: Kerr DJ, Workman P (eds) New targets for cancer chemotherapy. CRC Press, Baton Rouge, p 81
14. 14. Powis G, Bonjouklian R, Berggren MM, Gallegos A, Abraham R, Ashendel C, Zalkow L, Matter WF, Dodge J, Grindey G, Vlahos CJ (1994) Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res 54: 2419
15. 15. Ryu SH, Kim U-H, Wahl MI, Brown AB, Carpenter G, Huang K-P, Rhee SG (1990) Feedback regulation of phospholipase C by protein kinase C. J Biol Chem 265: 17941
16. 16. Schultz RM, Merriman RL, Andis SL, Bonjouklian R, Grindey GB, Rutherford PG, Gallegos A, Massey K, Powis G (1995) In vitro and in vivo antitumor activity of the phosphatidylinositol-3-kinase inhibitor, wortmannin. Anticancer Res 15: 1135
17. 17. Serunian LA, Auger KR, Roberts T, Cantley LC (1989) Production of novel polyphosphoinositides in vivo is linked to cell transformation by polyomavirus middle T antigen. J Virol 64: 4718
18. 18. Sjölander A, Yamamoto K, Huber BE, Lapetina EG (1991) Association of p21ras with phosphatidylinositol 3-kinase. Proc Natl Acad Sci USA 88: 7908
19. 19. Stephens L, Cooke FT, Walters R, Jackson T, Volinia S, Gout I, Waterfield MD, Hawkins PT (1994) Characterization of a phosphatidylinositol-specific phosphoinositide 3-kinase from mammalian cells. Curr Biol 4: 203
20. 20. Thomason PA, James SR, Casey PJ, Downes CP (1994) A G-protein beta-subunit-responsive phosphoinositide 3-kinase activity in human platelet cytosol. J Biol Chem 269: 16525
21. 21. Toker A, Cantley LC (1997) Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387: 673
22. 22. Wymann MP, Bulgarelli-leva G, Zvelebil MJ, Pirola L, Vanhaesebroeck B, Waterfield MD, Panayotou G (1996) Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 16: 1722
23. 23. Yao R, Cooper GM (1995) Requirement for phosphatidylinositol-kinase in the prevention of apoptosis by nerve growth factor. Science 267: 2003